Blood mitochondrial DNA as a biomarker of clinical outcomes in idiopathic pulmonary fibrosis

Eur Respir J. 2020 Nov 26;56(5):2001769. doi: 10.1183/13993003.01769-2020. Print 2020 Nov.

Authors

Hee-Young Yoon¹, Kwanghun Choi¹, Miae Kim¹, Hak-Su Kim², Jin Woo Song¹

Affiliations

¹ Dept of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Veterans Medical Research Institute, Veterans Health Service Medical Center, Seoul, Republic of Korea.

PMID: 32499337
DOI: 10.1183/13993003.01769-2020

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers
DNA, Mitochondrial* / genetics
Humans
Idiopathic Pulmonary Fibrosis* / diagnosis
Mitochondria

Substances

Biomarkers
DNA, Mitochondrial